Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis

Journal of Korean Medical Science

Volumn 20, Issue 3, 2005, Pages 450-455

  Jeong, Seok Hwa ^a   Hyo, Jin Park ^a   Jae, Hun Jung ^a   Sung, Chul Kam ^a   Hyung, Chul Park ^a   Choong, Won Kim ^a   Kee, Ryeon Kang ^a   Jea, Seog Hyun ^a   Ky, Hyun Chung ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Alpha 1 Antitrypsin; Carcinoma, Renal Cell; Electrophoresis, Gel, Two Dimensional; Kidney; Proteomics; Vimentin

Indexed keywords

ALDEHYDE REDUCTASE; ALPHA 1 ANTITRYPSIN; AMINOACYLASE; ENOYL COENZYME A HYDRATASE; KETOHEXOKINASE; TROPOMYOSIN; VIMENTIN;

ALPHA CHAIN; ANALYTIC METHOD; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; SILVER STAINING; STUDENT T TEST; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 21344456396     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.3.450     Document Type: Article

References (29)

1. Mydlo JH. Growth factors and renal cancer: characterization and therapeutic implications. World J Urol 1995; 13: 356-63.
2. Stenzl A, deKernion JB. The natural history of renal cell carcinoma. Semin Urol 1989; 7: 144-8.
3. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-23.
4. Vasavada SP, Novick AC, Williams BR. p53, bcl-2, and Bax expression in renal cell carcinoma. Urology 1998; 51: 1057-61.
5. Ji H, Reid GE, Moritz RL, Eddes JS, Burgess AW, Simpson RJ. A two-dimensional gel database of human colon carcinoma proteins. Electrophoresis 1997; 18: 605-13.
6. Hirano T, Franzen B, Uryu K, Okuzawa K, Alaiya AA, Vanky F, Rodrigues L, Ebihara Y, Kato H, Auer G. Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma. Br J Cancer 1995; 72: 840-8.
7. Giometti CS, Williams K, Tollaksen SL. A two-dimensional electrophoresis database of human breast epithelial cell proteins. Electrophoresis 1997; 18: 573-81.
8. Sarto C, Marocchi A, Sanchez JC, Giannone D, Frutiger S, Golaz O, Wilkins MR, Doro G, Cappellano F, Hughes G, Hochstrasser DF, Mocarelli P. Renal cell carcinoma and normal kidney protein expression. Electrophoresis 1997; 18: 599-604.
9. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, Novick A. TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 992-3.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
11. Jin SH, Cho EH, Ko JE, Jung EH, Ahn B, Hahm JR, Kim JW, Kim CW, Kim DR. Comparative analysis of nuclear proteins of B cells in different developmental stages. Proteomics 2003; 3: 2428-36.
12. Kellner R, Lichtenfels R, Atkins D, Bukur J, Ackermann A, Beck J, Brenner W, Melchior S, Seliger B. Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance. Proteomics 2002; 2: 1743-51.
13. Balabanov S, Zimmermann U, Protzel C, Scharf C, Klebingat KJ, Walther R. Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel eletrophoresis. Eur J Biochem 2001; 268: 5977-80.
14. Seliger B, Menig M, Lichtenfels R, Atkins D, Bukur J, Halder TM, Kersten M, Harder A, Ackermann A, Beck J, Muehlenweg B, Brenner W, Melchior S, Kellner R, Lottspeich F. Identification of markers for the selection of patients undergoing renal cellcarcinoma-specific immunotherapy. Proteomics 2003; 3: 979-90.
15. Dallmann K, Junker H, Balabanov S, Zimmermann U, Giebel J, Walther R. Human agmatinase is diminished in the clear cell type of renal cell carcinoma. Int J Cancer 2004; 108: 342-7.
16. Droz D, Zachar D, Charbit L, Gogusev J, Chretein Y, Iris L. Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol 1990; 137: 895-905.
17. Lindner H, Hopfner S, Tafler-Naumann M, Miko M, Konrad L, Rohm KH. The distribution of aminoacylase I among mammalian species and localization of the enzyme in porcine kidney. Biochimie 2000; 82: 129-37.
18. Cook RM, Franklin WA, Moore MD, Johnson BE, Miller YE. Mutational inactivation of aminoacylase-I in a small cell lung cancer cell line. Genes Chromosomes Cancer 1998; 21: 320-5.
19. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DS, Dean M, Glavac D, Richards FM, Crossy PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-20.
20. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994; 54: 2852-5.
21. Flynn TG. Aldehyde reductases: monomeric NADPH-dependent oxidoreductases with multifunctional potential. Biochem Pharmacol 1982; 31: 2705-12.
22. Barski OA, Gabbay KH, Grimshaw CE, Bohren KM. Mechanism of human aldehyde reductase: characterization of the active site pocket. Biochemistry 1995; 34: 11264-75.
23. Cohen C, McCue PA, Derose PB. Histogenesis of renal cell carcinoma and renal oncocytoma. An immunohistochemical study. Cancer 1988; 62: 1946-51.
24. Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994; 269: 15957-60.
25. Donaldson IA, Doyle TC, Matas N. Expression of rat liver ketohexokinase in yeast results in fructose intolerance. Biochem J 1993; 291: 179-86.
26. Tsuda H, Hacker HJ, Katayama H, Masui T, Ito N, Bannasch P. Correlative histochemical studies on preneoplastic and neoplastic lesions in the kidney of rats treated with nitrosamines. Virchows Arch B Cell Pathol Incl Mol Pathol 1986; 51: 385-404.
27. Singh M, Singh VN, August JT, Horecker BL. Alterations in glucose metabolism in chick embryo cells transformed by Rous sarcoma virus. Transformation-specific changes in the activities of key enzymes of the glycolytic and hexose monophosphate shunt pathways. Arch Biochem Biophys 1974; 165: 240-6.
28. Beemer FA, Vlug AM, Rousseau-Merck MF, van Veelen CW, Rijksen G, Staal GE. Glycolytic enzymes from human neuroectodermal tumors of childhood. Eur J Cancer Clin Oncol 1984; 20: 253-9.
29. Beemer FA, Vlug AM, Rijksen G, Hamburg A, Staal GE. Characterization of some glycolytic enzymes from human retina and retinoblastoma. Cancer Res 1982; 42: 4228-32.